APA (7th ed.) Citation

Schweihofer, V., Bruss, C., Seitz, S., Glehr, G., Hetterich, M., Weber, F., . . . Wege, A. K. (2025). Breast cancer scoring based on a multiplexed profiling of soluble and cell-associated (immune) markers facilitates the prediction of pembrolizumab therapy. Cancer Cell International, 25(1), 1. https://doi.org/10.1186/s12935-025-03729-7

Chicago Style (17th ed.) Citation

Schweihofer, Verena, et al. "Breast Cancer Scoring Based on a Multiplexed Profiling of Soluble and Cell-associated (immune) Markers Facilitates the Prediction of Pembrolizumab Therapy." Cancer Cell International 25, no. 1 (2025): 1. https://doi.org/10.1186/s12935-025-03729-7.

MLA (9th ed.) Citation

Schweihofer, Verena, et al. "Breast Cancer Scoring Based on a Multiplexed Profiling of Soluble and Cell-associated (immune) Markers Facilitates the Prediction of Pembrolizumab Therapy." Cancer Cell International, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12935-025-03729-7.